B. Braun Miethke


Ideas. Innovation. Implementation.


We care for a better life
for people with chronic pain.



B. Braun Miethke

Innovative products for targeted drug delivery

B. Braun Miethke GmbH & Co. KG is a joint venture between Aesculap AG, a subsidiary of the medical technology and pharmaceutical company B. Braun Melsungen AG, and Christoph Miethke, founder and CEO of Christoph Miethke GmbH & Co. KG located in Potsdam. This joint venture is a new chapter in the successful and long standing partnership between these two companies which will be strengthened by further collaboration and sharing of expertise.

Our focus is the development of innovative targeted drug delivery products with the goal of meeting unmet or poorly met user needs of patients and health care professionals.






"There are many opportunities for improvements in the targeted drug delivery field. We are developing innovative solutions with the aim to improve the therapy and usability of these systems. I am excited and honored to have the opportunity to build a team to tackle this challenge with the support of Christoph Miethke and B. Braun."

Brandon Loudermilk
CEO – B. Braun Miethke GmbH & Co. KG





"We are in the middle of development and it becomes more evident every day that our ideas work. Our aspiration is ambitious: to use innovative technology to overhaul the current state of the industry.  However, that’s just part of it…
I also really enjoy being involved in a company from the very beginning again."

Christoph Miethke
CEO - Christoph Miethke GmbH & Co. KG